Pharmacy Times

JULY 23, 2025

doi:10.1183/13993003.01794-2016 Leving MT, Kocks J, Bosnic-Anticevich S, Dekhuijzen R, Usmani OS. Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients. Eur Respir J. 2017;49(2):1601794.

Hospitals

Pharmacy Times

JUNE 27, 2025

Ross et al published a landmark study in 2016 evaluating psilocybin’s impact on anxiety and depression in 51 patients with life-threatening cancer. It triggered an outflow of new psychedelic research interest and added evidence to the relationship between mystical experience and the efficacy of psilocybin.

Compounding Pharmacies

Pharmacy Times

JULY 8, 2025

SHOW MORE The study found biosimilar initiation rose to nearly 42% from 2016 to 2023. These diseases are caused by a dysregulated mucosal immune response to the intestinal microflora in hosts who are genetically predisposed. Data came from the ICN Network and encompassed 4602 patients across 73 centers.

HIV Treatment and Prevention Agents

pharmaphorum

JUNE 24, 2025

Skip to main content Tuesday 24 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies

Drug Topics

JUNE 12, 2025

2 The therapy was previously granted breakthrough therapy designation by the FDA in 2016 for the treatment of patients with HCV who were not cured with prior DAA therapy based on data from the phase 2 MAGELLAN-1 study. December 19, 2016. 3 READ MORE: Infectious Disease Resource Center Pharmacy practice is always changing.

FDA

Pharmacy Times

JULY 1, 2025

031), and diagnosis between 2016 and 2018 (OR 1.93, P < 001) as well as 2019 and 2020 (1.88, P < 001). in 2016, representing a period of rapid uptake—and usage was consistently high from 2016 to 2018. 3 The utilization of HER2 therapies increased from 64.6% in 2013 to 80.9%

Compounding Pharmacies

The Thyroid Pharmacist

MARCH 7, 2025

1] This inability to detox properly can trigger or worsen autoimmune symptoms, as these chemical exposures can trigger immune dysregulation. [2] Reduced inflammation and joint pain Toxins can trigger the immune system, leading to chronic inflammation, joint pain, and autoimmune flares. Published 2016 Nov 17. 2016;13(11):1153.

Health and Personal Care Stores

The Thyroid Pharmacist

MAY 15, 2025

Additionally, high blood sugar can impair immune function, making it harder for the body to fight off infections. Takeaway Supporting a healthy gut microbiome may help reduce UTIs and also promote better thyroid function and immune balance in autoimmune conditions! August 22, 2016. Pediatr Res. 2023;93(4):1096-1104. Nature News.

Immunization

The Thyroid Pharmacist

MAY 9, 2025

Sex hormones have an influence on the immune system, so its no wonder that taking hormones in the form of birth control can affect the development of autoimmunity. Oral contraceptives stimulate a shift from the Th1 to the Th2 immune branch. This can produce an imbalance of the immune system, perpetuating autoimmune conditions.

Immunization

Pharmacy Times

JUNE 25, 2025

1 Scientific evidence between January 1, 2016, and January 31, 2023, was included in the study. This was assessed by analyzing real-world pharmacoepidemiological data and conducting a systematic review and meta-analysis to further quantify this risk.

Compounding Pharmacies

STAT

JUNE 24, 2025

She first joined the FDA in 2016 as the director of the office of medical policy at CDER and became the CDER deputy director in 2021. “Although the appointees to [the Advisory Committee on Immunization Practices] have scientific credentials, many do not have significant experience studying microbiology, epidemiology or immunology.

FDA

pharmaphorum

JUNE 26, 2025

Skip to main content Thursday 26 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies

pharmaphorum

JULY 17, 2025

Skip to main content Thursday 17 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Immunization

pharmaphorum

JULY 18, 2025

Skip to main content Friday 18 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies

pharmaphorum

JULY 17, 2025

Skip to main content Thursday 17 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Immunization

pharmaphorum

NOVEMBER 12, 2020

Founded in 2016 as a spin-out from Wuerzburg University, CatalYm’s lead molecule CTL-002 is designed to neutralise the tumour-produced protein GDF-15. High concentrations of the GDF-15 in serum and tumour-micro-environment help cancers to evade the immune system and are associated with resistance to current therapies.

Immunization

pharmaphorum

JUNE 1, 2021

Patients will also receive a dose of tacrolimus, an immune-suppressing drug, to guard against any immune reaction to the transplanted cells. The hope is that the spheroids will help to replenish damaged cardiomyocytes in the heart, restoring some of its ability to pump blood around the body.

Immunization

pharmaphorum

JULY 13, 2022

In 2016 it started a $1 billion alliance with AstraZeneca to find drug candidates that could be used to treat respiratory diseases, and extended that in 2018 to include cardiovascular and metabolic disorders. The agreement includes another $12 million to Bicycle, per candidate, if Genentech decides to take a peptide further in development.

Immunization

Pharmaceutical Technology

OCTOBER 14, 2022

In 2016, the companies entered a strategic partnership to develop novel messenger RNA (mRNA) based PCVs. The mRNA-4157/V940 has been designed to stimulate an immune response by producing T-cell responses depending on the mutational signature of a patient's tumour.

Vaccines

European Pharmaceutical Review

MAY 17, 2023

The viral therapy “aims to awaken the patient’s immune system and trigger a healing from within,” Dr Fueyo commented. After injection, patients that respond well develop inflammation inside the tumour, triggering an immune response that first kills the virus.” This makes it difficult to treat the cancer with immunotherapy.

Immunization

pharmaphorum

JANUARY 27, 2022

The first patient has been treated with an implantable bioelectronic device developed by Galvani Therapeutics, set up by GlaxoSmithKline and Alphabet’s Verily Life Sciences in 2016. Galvani is using its device to stimulate the splenic nerve, which sends signals to the spleen.

Immunization

European Pharmaceutical Review

DECEMBER 1, 2022

In order to speed up the regulatory process for advanced medicinal therapy products (ATMPS), the European Union (EU) implemented the priority medicines (PRIME) scheme in 2016. Since the COVID-19 pandemic, there has been a spike in interest in mRNA therapeutics, due to the success of mRNA vaccines treating the virus, observed GlobalData.

Vaccines

European Pharmaceutical Review

AUGUST 9, 2023

While injectable biologic therapies are an effective option for CSU that is uncontrolled by these drugs, less than 20 percent of patients worldwide are treated with them, according to a 2016 British Journal of Dermatology paper and research shared by Novartis. In REMIX-2, the clinical trial enrolled 455 participants with CSU.

Immunization

European Pharmaceutical Review

JANUARY 26, 2023

CAR T-cell therapy engineers a patient’s own immune cells (T-cells) to detect, target and destroy cancer cells. Could CAR T therapies be manufactured in one day?

Chemotherapy

pharmaphorum

JANUARY 7, 2022

Sanofi and Exscientia first started working together in 2016, initially on a fairly small-scale programme focused on bispecific small-molecule drugs for metabolic diseases, with a total value of around $275 million. The French drugmaker is paying $100 million upfront in the deal, but the total value could swell to a massive $5.2

Immunization

The Checkup by Singlecare

FEBRUARY 8, 2024

In people with inflammatory diseases like eczema, food sensitivities start a cascade in the immune system that leads to a flare. Fermented foods The gut, skin, and immune system are closely connected, so it’s no surprise that gut- and immune-boosting foods may also improve skin conditions like eczema.

Immunization

European Pharmaceutical Review

AUGUST 26, 2022

Moderna has filed patent infringement lawsuits alleging that Pfizer and BioNTech’s COVID-19 vaccine Comirnaty ® infringes patents Moderna filed between 2010 and 2016 covering its foundational messenger RNA (mRNA) technology. ” But why sue now?

Vaccines

European Pharmaceutical Review

DECEMBER 20, 2022

This technology is creating an entirely new class of molecules to induce synthetic immunity against cancer by harnessing NK cell effector functions against cancer cells and also providing proliferation and activation signals targeted to NK cells. Building on Sanofi’s and Innate Pharma’s original license agreement.

Immunization

The Checkup by Singlecare

JANUARY 4, 2024

Effects on the immune system Alcohol may negatively affect your immune system’s ability to fight off infections, especially in people who drink large amounts over time. A weakened immune system could delay recovery, which may cause you to rely on medications like Mucinex to control symptoms.

Immunization

The People's Pharmacy

JUNE 15, 2023

In the research laboratory, the primary question being investigated is the role of the skin and resident cells, including mast cells and basophils, in allergic immune responses. at the University of North Carolina School of Medicine, Monday, February 29, 2016 in Chapel Hill. Photo by Chris Polydoroff.

Research Laboratories

The Thyroid Pharmacist

JUNE 30, 2023

However, low doses of this medication (hence, low dose naltrexone or LDN), have been found to modulate the immune system and have shown promise in improving cases of autoimmune disease. These include Crohn’s, MS, and Hashimoto’s, as well as other immune system-related conditions such as cancer and HIV/AIDS. Doses of 1.5-4.5

Compounding

pharmaphorum

SEPTEMBER 2, 2020

Vopratelimab is a monoclonal antibody that binds to and activates the Inducible T Cell CO-Stimulator (ICOS), a protein on the surface of certain T cells that is believed to stimulate an immune response against a patient’s cancer. In 2016 Celgene signed a $2.6

Immunization

pharmaphorum

JUNE 9, 2021

After transplant, the 10 subjects in the study will take immunosuppressant drugs to prevent their immune system from rejecting the transplant. They will be followed up for two years, looking at safety, tolerability, the survival of the cells and the impact on Parkinson’s symptoms, with final results due in November 2023.

Immunization

European Pharmaceutical Review

JUNE 13, 2023

In IgAN, autoimmune reaction to an abnormal form of IgA results in formation of immune complexes that deposit in the kidney. These immune complexes trigger inflammation and kidney damage. This then leads to progressive loss of renal function, according to a 2016 paper published in Nature Reviews Disease Primers. The post £2.5b

Immunization

European Pharmaceutical Review

SEPTEMBER 5, 2024

2 These are cells commonly found in the stroma of the tumour, which play an important role in inhibiting the body’s own immune response to the tumour, mediated through CD8+ T-cells (tumour-infiltrating lymphocytes). Research in the last few years has shown NOX4 in tumour cells is linked to the growth of cancer-associated fibroblasts (CAFs).

Immunization

The Checkup by Singlecare

NOVEMBER 9, 2023

Although a large 2016 study concluded that steam inhalation may not be effective for sinus infections, it’s still recommended home remedy by the Centers for Disease Prevention and Control. Research has shown that getting enough rest is essential for your immune system to mount a defense against infections and inflammations.

Immunization

Hospital Pharmacy Europe

SEPTEMBER 29, 2022

RP2 oncolytic therapy involves genetically engineered viruses designed to target and kill cancer cells while sparing normal cells and activating the host immunity to recognise and attack the tumour. T-VEC was also approved by the EMA in 2016. Consequently, blockage of CTLA-4 function promotes immune-mediated tumour regression.

Immunization